Company: COHN
Filing Date: 2025-12-02
Form Type: SCHEDULE 13D/A
Source: 0001104659-25-117695
Chunk: 0

Company: Cohen & Co Inc.
Filing Date: 2025-12-02
Form: SCHEDULE 13D/A
Chunk 0
---
 Instructions) |
| 13                                                                 |                                                                              15.51 % |
| 14                                                                 |                                                                                   IN |

Comment for Type of Reporting Person: (1) Includes 40,000 restricted shares of the common stock, par value $0.01 per share ("Common Stock"), of Cohen & Company Inc., a Maryland corporation, held directly by Lester R. Brafman (the "Reporting Person"), the restrictions on which will expire on January 31, 2026. Upon the expiration of such restrictions on January 31, 2026, which date is within 60 days of the date of this Amendment No. 5 to Schedule 13D, the Reporting Person will acquire both voting and dispositive control over all such shares of Common Stock. Accordingly, the Reporting Person may be deemed to be the beneficial owner of all of such 40,000 restricted shares of Common Stock, which shares are the subject of this Amendment No. 5 to Schedule 13D.

| SCHEDULE 13D |

| Item 1.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | Security and Issuer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| (a)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | COMMON STOCK, PAR VALUE $0.01 PER SHARE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| (b)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | Cohen & Co Inc.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| (c)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | Cira Centre, 2929 Arch Street, Suite 1703, Philadelphia,                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
 PENNSYLVANIA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
 , 19104-2870.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Item 1 Comment:This Amendment No. 5 to Schedule 13D is filed to amend Items 3, 4 and 5 of the Schedule 13D filed with the Securities and Exchange Commission (the "SEC") on February 16, 2021, as amended by Amendment No. 1 to Schedule 13D filed with the SEC on December 3, 2021; as amended by Amendment No. 2 to Schedule 13D filed with the SEC on December 5, 2022; as amended by Amendment No. 3 to Schedule 13D filed with the SEC on December 4, 2023; and as amended by Amendment No. 4 to Schedule 13D filed with the SEC on December 2, 2024 (as so amended, the "Schedule 13D"). Except as